...
首页> 外文期刊>Stem cell research >Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene
【24h】

Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene

机译:从患有帕金森病疾病的患者产生诱导的多能干细胞系(CSC-32)在SNCA基因中携带杂合变异P.a53t

获取原文

摘要

Here, we describe the generation of an induced pluripotent stem cell (iPSC) line, from a male patient diagnosed with Parkinson's disease (PD). The patient carries a heterozygous variation p.A53T in the SNCA gene. Skin fibroblasts were reprogrammed using the non-integrating Sendai virus technology to deliver OCT3/4, SOX2, c-MYC and KLF4 factors. The generated iPSC line (CSC-32) preserved the mutation, displayed expression of common pluripotency markers, differentiated into derivatives of the three germ layers, and exhibited a normal karyotype. The clone CSC-32B is presented thereafter; it can be used to study the mechanisms underlying PD pathogenesis.
机译:在这里,我们描述了诱导的多能干细胞(IPSC)系列的产生来自诊断患有帕金森病(PD)的男性患者。患者在SNCA基因中携带杂合子变异p.a53t。使用非整合仙台病毒技术重新编程皮肤成纤维细胞,以递送OCT3 / 4,SOX2,C-MYC和KLF4因子。所产生的IPSC线(CSC-32)保留了突变,显示常见多能性标志物的表达,分化为三种胚层的衍生物,并表现出正常的核型。此后提出了克隆CSC-32B;它可用于研究Pd发病机制下面的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号